|
Symbol
|
BCSBIL | MABBJB | MAPTJB | ZMAH5V | MAQGJB | MAKGJB | LVCXLK | MAFQJB | MASEJB | AHHETQ | AHHCTQ | AAZMSP |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Barrier Express Certificate | Express Certificate | Express Certificate | Express Voncert* | Multi Express Certifikat with European Knock-In | Multi Express Certifikat with European Knock-In | LUKB Autocallable Multi Barrier Reverse Convertible | Multi Express Certifikat with European Knock-In | Multi Express Certifikat with European Knock-In | Express Certificate with European Knock-In | Express Certificate with European Knock-In | Barrier Reverse Convertible with Conditional Coupon |
|
Underlying
|
Novartis AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé / Novartis / UBS / Zurich | Nestlé / Novartis / UBS / Zurich | Novo Nordisk, AstraZeneca, Roche, Novartis Basket |
|
Issuer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of maturity
|
02.10.2030 | 04.02.2028 | 04.02.2028 | 30.04.2029 | 30.04.2029 | 30.04.2029 | 12.08.2027 | 05.01.2029 | 05.01.2029 | 22.07.2030 | 22.07.2030 | 07.10.2033 |
| Ratio | 0.0967 | - | - | - | - | - | - | - | - | - | - | - |
|
Strike price
|
- | - | - | - | - | - | - | - | - | - | - | - |
| Bid | 100.98 | - | - | 97.12 | - | - | - | - | - | 97.96 | 98.44 | - |
| Ask | 101.79 | - | - | 98.90 | - | - | - | - | - | 98.76 | 99.24 | - |